ArticleJournal of hepato-biliary-pancreatic sciences2025
The efficacy of 3D hologram support with mixed-reality technique in pancreatobiliary endoscopy.
Article in Journal of hepato-biliary-pancreatic sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Mixed-reality-based remote endoscopic retrograde cholangiopancreatography education using a three-dimensional anatomical model.Endoscopy · 2026Article
- Mixed-reality-based education with holographic support before and during ERCP-related procedures.Endoscopy · 2025Article
- Successful guidewire insertion into the gallbladder facilitated by a mixed-reality-based three-dimensional anatomical model.Endoscopy · 2025Article
- The efficacy of 3D hologram support with mixed-reality technique in pancreatobiliary endoscopy.Journal of hepato-biliary-pancreatic sciences · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimsMixed-reality (MR) technology is an advanced holographic imaging system that uses wearable devices to display three-dimensional (3D) images in clinical environments. In pancreatobiliary endoscopy, MR technology can facilitate 3D visualization of the bile and pancreatic ducts, enhancing spatial awareness and providing a more intuitive understanding of the anatomy. We evaluated the safety and efficacy of 3D hologram support (3D-HS) using MR in pancreatobiliary endoscopy.
methodsThis study included 30 patients who underwent pancreatobiliary endoscopy using 3D-HS between June 2023 and July 2024. The procedures included ERCP (n = 13) and interventional EUS (iEUS) (n = 17). The primary outcome was technical success, with secondary outcomes including total procedure-related time and adverse events. The conventional treatment group, matched for age and disease type, was compared to the 3D-HS group. a questionnaire was used to evaluate the MR device, 3D hologram images, and the overall evaluation with 3D-HS.
resultsThe overall technical success rate was 96.7% (ERCP, 100%; iEUS, 93.8%). Adverse events occurred in 16.7% of cases; all were managed conservatively. comparison with conventional treatment showed no significant differences in outcomes, although conventional methods had shorter procedural times (p < 0.05). The questionnaire results indicated positive feedback on operability and image quality of 3D-HS, with enhanced anatomical understanding relative to 2D imaging, although some ERCP cases received lower ratings, particularly for intrahepatic bile duct stones.
conclusionsPancreatobiliary endoscopy using 3D-HS can be safe and effective in enhancing anatomical understanding. Further studies are needed to optimize its use and reduce the total procedure time.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.